{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:09:37Z","timestamp":1785848977710,"version":"3.56.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ygyno.2012.07.098","type":"journal-article","created":{"date-parts":[[2012,7,22]],"date-time":"2012-07-22T01:00:20Z","timestamp":1342918820000},"page":"412-419","source":"Crossref","is-referenced-by-count":88,"title":["Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma"],"prefix":"10.1016","volume":"127","author":[{"given":"Qinghua","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huafeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Morihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Kiviat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingegerd","family":"Hellstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Erik","family":"Hellstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.07.098_bb0005","first-page":"1","article-title":"Tumor antigens","volume":"5","author":"Hellstrom","year":"1979"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.iy.12.040194.002005","article-title":"Tumor antigens recognized by T lymphocytes","volume":"12","author":"Boon","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0015","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/35077246","article-title":"Progress in human tumour immunology and immunotherapy","volume":"411","author":"Rosenberg","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0025","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0030","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0035","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0959-8049(99)00291-9","article-title":"Viruses in human cancers","volume":"35","author":"zur Hausen","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0040","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.4049\/jimmunol.148.8.2617","article-title":"Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16","volume":"148","author":"Chen","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1073\/pnas.88.1.110","article-title":"Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen","volume":"88","author":"Chen","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0050","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","article-title":"Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia","volume":"361","author":"Kenter","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0055","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1086\/656367","article-title":"Evaluation of immunological cross-reactivity between clade A9 high-risk human papillomavirus types on the basis of E6-specific CD4+ memory T cell responses","volume":"202","author":"van den Hende","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers \u2014 a brief historical account","volume":"384","author":"zur Hausen","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0065","first-page":"661","article-title":"Studies on specific transplantation resistance against polyoma virus-induced tumors. IV. Stability of the polyoma cell antigen","volume":"32","author":"Sjogren","year":"1964","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0070","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(05)79490-3","article-title":"Screening for cervical cancer","volume":"351","author":"Cuzick","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00003081-199906000-00006","article-title":"Advances in the diagnosis and treatment of human papillomavirus infections","volume":"42","author":"Sedlacek","year":"1999","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0080","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/infdis\/159.2.293","article-title":"Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic","volume":"159","author":"Kiviat","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0090","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ajcp\/102.2.182","article-title":"Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types","volume":"102","author":"Sherman","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0095","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.4049\/jimmunol.167.5.2972","article-title":"Predominant Th2\/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer","volume":"167","author":"Sheu","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0100","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/modpathol.2010.109","article-title":"Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression","volume":"23","author":"Ovestad","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0110","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1158\/0008-5472.CAN-11-1156","article-title":"Targeting regulatory T cells in cancer","volume":"71","author":"Byrne","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0115","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","article-title":"CD20+ B cells: the other tumor-infiltrating lymphocytes","volume":"185","author":"Bh","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00277-002-0437-8","article-title":"Syndecan-1 in B lymphoid malignancies","volume":"81","author":"Sanderson","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1385\/IR:29:1-3:219","article-title":"Functional regulation of human neutrophil Fc gamma receptors","volume":"29","author":"Selvaraj","year":"2004","journal-title":"Immunol Res"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","article-title":"IgG Fc receptors","volume":"19","author":"Ravetch","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0135","doi-asserted-by":"crossref","first-page":"13968","DOI":"10.1073\/pnas.0906367106","article-title":"Helminth products bypass the need for TSLP in Th2 immune responses by directly modulating dendritic cell function","volume":"106","author":"Massacand","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ni.1852","article-title":"Sensing the outside world: TSLP regulates barrier immunity","volume":"11","author":"Ziegler","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0145","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20051135","article-title":"TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand","volume":"202","author":"Ito","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0150","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.2174\/092986711795656045","article-title":"Indoleamine 2,3-dioxygenase, Tregs and cancer","volume":"18","author":"Munn","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0155","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nm.2438","article-title":"Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido","volume":"17","author":"Balachandran","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20101876","article-title":"Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer","volume":"208","author":"De Monte","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0165","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20102131","article-title":"Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation","volume":"208","author":"Pedroza-Gonzalez","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0175","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.humpath.2004.08.012","article-title":"Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions","volume":"35","author":"Azar","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnci\/89.3.245","article-title":"Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection","volume":"89","author":"Clerici","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0185","first-page":"533","article-title":"Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix","volume":"49","author":"Mindiola","year":"2008","journal-title":"Invest Clin"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0190","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jcp.48.9.876","article-title":"A \u201cquickscore\u201d method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas","volume":"48","author":"Detre","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0195","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/eji.1830250935","article-title":"Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors","volume":"25","author":"Feltkamp","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0200","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/eji.1830230929","article-title":"Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells","volume":"23","author":"Feltkamp","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jcb.21468","article-title":"Vaccines to treat cancer \u2014 an old approach whose time has arrived","volume":"102","author":"Hellstrom","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0210","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1086\/424466","article-title":"Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents","volume":"190","author":"Moscicki","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0215","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/cgt.2011.8","article-title":"Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models","volume":"18","author":"Liu","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0220","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1158\/0008-5472.CAN-06-4296","article-title":"Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses","volume":"67","author":"Tuve","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0225","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/mi.2008.33","article-title":"Evolving immunosuppressive microenvironment during human cervical carcinogenesis","volume":"1","author":"Kobayashi","year":"2008","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0230","first-page":"2629","article-title":"Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer","volume":"31","author":"Fotopoulou","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0235","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1349-7006.2007.00470.x","article-title":"Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer","volume":"98","author":"Nakamura","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0240","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/204846a0","article-title":"Effect on tumor growth in syngeneic recipients of antibodies against tumor-specific antigens in methylcholanthrene-induced mouse sarcomas","volume":"204","author":"Moller","year":"1964","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0245","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1073\/pnas.62.2.362","article-title":"Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens","volume":"62","author":"Hellstrom","year":"1969","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0250","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1073\/pnas.68.6.1372","article-title":"Suggestive evidence that the \u201cblocking antibodies\u201d of tumor-bearing individuals may be antigen\u2013antibody complexes","volume":"68","author":"Sjogren","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0255","first-page":"185","article-title":"Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen\u2013antibody complexes","volume":"238","author":"Baldwin","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0260","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0065-2776(08)60311-9","article-title":"Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens","volume":"18","author":"Hellstrom","year":"1974","journal-title":"Adv Immunol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0265","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccr.2005.04.014","article-title":"De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent","volume":"7","author":"de Visser","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2009.12.019","article-title":"FcRgamma activation regulates inflammation-associated squamous carcinogenesis","volume":"17","author":"Andreu","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0275","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<313::AID-IJC3>3.0.CO;2-W","article-title":"Antibodies againsdt oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia","volume":"85","author":"Zumbach","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0280","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00705-006-0787-y","article-title":"Correlation between serological immune response analyzed by a new ELISA for HPV-16\/18 E7 oncoprotein and clinical characterristics of cervical cancer patients","volume":"151","author":"Ravaggi","year":"2006","journal-title":"Arch Virol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0285","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/08828240152716655","article-title":"Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia","volume":"14","author":"Tjiong","year":"2001","journal-title":"Viral Immunol"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0290","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1073\/pnas.0500014102","article-title":"Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells","volume":"102","author":"Dhodapkar","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0295","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1172\/JCI24772","article-title":"Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions","volume":"115","author":"Boruchov","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0300","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.1206954","article-title":"Inhibitory Fcgamma receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies","volume":"333","author":"Li","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0305","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1084\/jem.20020338","article-title":"Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells","volume":"195","author":"Kalergis","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0310","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20102131","article-title":"Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation","volume":"208","author":"Pedroza-Gonzalez","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0315","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20101876","article-title":"Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer","volume":"208","author":"De Monte","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.ygyno.2012.07.098_bb0320","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1126\/science.176.4031.170","article-title":"The immune response as a stimulator of tumor growth","volume":"176","author":"Prehn","year":"1972","journal-title":"Science"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812006191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812006191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T15:51:01Z","timestamp":1687621861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812006191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0090825812006191"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.07.098","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}